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Abstract
Background: Coccidioidomycosis is usually a self-limited infection in immunocompentent people. In
immunocompentent human beings second infections due to Coccidioides are very rare, indicating that recovery
from infection results in protective immunity. In experimental animals, immunization with several different proteins
or attenuated mutants protects against a virulent challenge. To explore what mechanisms are responsible for
protective immunity, we investigated the course of Coccidioides infection in the gp91
phox knock out mouse that
has a defect in the oxidative burst that results in chronic granulomatous disease.
Results: We found that the gp91
phox knock out mice were somewhat more resistant to intraperitoneal infection
and equally as resistant to low dose intranasal infection, but slightly more susceptible to high dose intranasal
infection compared to control mice. The gp91
phox knock out mice made a more robust inflammatory response to
infection than controls, as measured by histology and production of inflammatory cytokines. The gp91
phox knock
out mice were as protected by immunization with the recombinant Coccidioides protein Ag2/PRA as the controls
were against either intraperitoneal or intranasal infection. Coccidioides immitis arthroconidia and spherules were
significantly more resistant to H2O2 treatment in vitro than Aspergillus fumigatus spores.
Conclusion: These data suggest that oxidative burst may not be required for protective immunity to
coccidioidomycois.
Keywords: Coccidioidomycosis host response, oxidative burst
Background
Coccidioides immitis and posadasii are pathogenic fungi
that grow in the arid soils of the southwestern United
States, Mexico and Central and South America. Mycelia in
the soil give rise to infectious arthroconidia, which, when
aerosolized, can be inhaled. The severity of coccidioidomy-
cois (Valley Fever) ranges from a mild self-limited disease
to a severe pneumonia and widely disseminated infection
requiring lifelong antifungal therapy [1]. The risk factors
for the more severe forms of disease include ethnic back-
ground (Filipino, African-American, Hispanic), male sex,
increasing age, pregnancy and immunosuppression (HIV,
malignancy, organ transplantation) [2-4].
The role of polymorphonuclear leukocytes (PMNs)
macrophages and the oxidative burst in the defense
against Coccidioides is not clearly defined. PMN’s are the
first cell to respond to inhaled arthroconidia [5]. Although
arthroconidia are sensitive to products of the oxidative
burst [6,7] and are phagocytosed by PMNs [8-10], fewer
than 20% of arthroconidia are killed by human PMNs
[8,9,11,7]. Once arthroconidia mature into spherules they
become resistant to phagocytosis and PMN killing because
of their size (60-80 microns) [9,12]. The extracellular
matrix of spherules also appears to resist attachment by
PMNs [9]. Rupture of spherules releases endospores that
have been shown to activate the oxidative burst and are
r e a d i l yp h a g o c y t o s e db yP M N ’s [9,11]. In spite of this,
endospores appear to be resistant to killing by PMNs
[9,11]. There has not been an adequate study of Cocci-
dioides in a neutropenic infection model, to understand
the importance of neutrophils and macrophages on
disease progression.
Coccidioidomycois is usually a self-limited infection. In
immunocompentent people pulmonary infections resolve
without drug treatment greater than 95% of the time [1].
In addition, human infection leads to protective immunity
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mice [13-17]. We have found that the protective immunity
to antigen 2/proline rich antigen (Ag2/PRA) in mice
requires MHC-Class II-dependent CD4 cells but did not
require CD8 T-cells [18]. IL-12 is also required, suggesting
that a Th1 immune response was important for protective
immunity [18]. Mice lacking interferon-g were not pro-
tected by immunization with Ag2/PRA [18]. One issue
these studies did not address was what type of effector
mechanism was responsible for actually killing the fungus
or inhibiting its growth. Because reactive oxygen inter-
mediates are so important for natural resistance to Asper-
gillus species, we asked what role this mechanism plays in
natural and acquired resistance to coccidioidomycosis
using the gp91
phox knock out (KO) mouse.
To address the role of the oxidative burst, we used
C56Bl/6 mice with a deletion in the NADPH oxidase gene
gp91. These mice were developed in 1995 by Pollack as a
chronic granulomatous disease (CGD) mouse model [19].
This mouse is characterized by functionally defective
PMNs and macrophages because of a mutation in NADPH
oxidase in the X-linked gene gp91
phox (where phox stands
for phagocyte oxidase). This gene encodes a 91 kD subunit
of the oxidase cytochrome b. These mice have increased
susceptibility to Aspergillus and Staphylococcus aureus
infection because of ineffective oxidative killing by their
PMNs. In this study we analyze the response of the
gp91
phox KO mice to infection with Coccidioides immitis
and evaluate the response of these mice to immunization.
Methods
Mice
B6.129S6-Cybb
tm1Din/J (referred to as gp91
phox KO)
mouse breeding pairs were obtained from Jackson
Laboratory (Bar Harbor, ME) and bred in a specific
pathogen free environment. Both male and female mice
express the gp91
phox mutation. 6-12 week old female
mice were used for all experiments. C57Bl/6J female
(B6) mice 6-12 week old micew e r eu s e da sc o n t r o l s .
The Subcommittee on Animal Studies approved all
experimental protocols involving animals.
Fungus
The R.S. strain of C. immitis was used as the challenge
strain. Cultures of mycelia were harvested after 60 days.
Arthroconidia were prepared from mycelia as previously
described [13].
Immunization and infection
Mice were immunized with 2 μg Ag2/PRA [14] (a gift of
Dr. John Galgiani) and 10 μg of CpG oligonucleotide
[18] in a 50/50 emulsion of saline and mineral oil,
injected in a total volume of 0.2 ml subcutaneously.
Non-immune controls were injected with 0.2 ml of a
50/50 emulsion of saline and mineral oil subcutaneously.
The immunization or control injection was repeated
14 days later. 14 days later (28 days after the first immu-
nization) the mice were challenged with 150 R.S arthro-
conidia in 0.5 ml saline into the intraperitoneal space
(I.P.). 14 days after the challenge the mice were eutha-
nized. The left lung was removed, homogenized in 2 ml
saline, serially diluted, and quantitative culture done.
Pulmonary infection was initiated with 150 or 250
arthroconidia intranasally in 20 μl saline after mice were
anesthetized with ketamine and xylazine (0.1 ml of a cock-
tail containing ketamine (15 mg/ml), xylazine (16 mg/ml)
in saline was injected i.p). After infection, they were rested
on a heating pad and monitored until they woke up in
about 1 h. The mice were monitored for mortality for
30 days.
Real-time Quantitative PCR for Lung Cytokines
Groups of 4 mice were infected with 150 arthroconidia
I.P. Twelve days after infection the upper lobe of the
right lung of a mouse was removed into 2 ml Ultraspec
(Biotecx) and immediately homogenized. Total RNA
was extracted as described in the manufacturer’sp r o t o -
col. RNA was quantified and analyzed for integrity using
a Bioanalyzer (Biorad Experion). cDNA was synthesized
using superscript VILO cDNA synthesis kit (Invitrogen).
Taqman gene-specific primer/probes for mouse cyto-
kines and 18S were purchased from Applied Biosystems.
The real-time quantitative PCR reactions and data ana-
lysis were carried out by UCSD CFAR genomic core
according to the manufacturer’sp r o t o c o lu s i n ga nA B I
Prism 7900 HT sequence detection system. Amplifica-
tion of 18S RNA was performed to standardize the
amount of sample added to each reaction.
Susceptibility to Oxidative Stress
Aspergillus fumigatus spores were harvested from
mature slants in distilled water. C. immitis arthroconidia
were harvested from mycelia by beating with glass beads
as previously described [13]. C. immitis spherules were
g r o w ni nm o d i f i e dC o n v e r s em e d i af o r7d a y sa sp r e -
viously described [20]. About 200 organisms were incu-
bated with various concentrations of H2O2 in 1 ml
saline for 45 minutes at room temperature. The fungi
were collected by centrifugation, washed in saline by
centrifugation and the sediment cultured on glucose
yeast extract agar. The number of colonies was counted
and compared to a control that was processed as above
but not treated with H2O2. Each experimental point was
determined in triplicate; the mean and S.E.M. is plotted.
Statistics
All quantitative culture data and quantitative mRNA
data was compared using theM a n n - W h i t n e yUt e s t .
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Both tests were done with Prism GraphPad 4 software
(San Diego, CA).
Results
We initially tested the innate resistance of gp91
phox KO
mice to intraperitoneal infection with C. immitis.T h e
number of CFU/lung was determined by quantitative
culture on day 14. Figure 1A shows the results. The
gp91
phox KO mice had slightly lower numbers of CFU/
lung compared to the B6 controls (p < 0.001, Mann-
Whitney U). We then compared the innate and acquired
resistance of C57Bl/6 mice and the gp91
phox KO mice to
intraperitoneal challenge with C. immitis.A n i m a l sw e r e
i m m u n i z e dw i t hA g 2 / P R Aa sd e s c r i b e di nM e t h o d s .
They, and non-immune controls were challenged with
150 arthroconidia I.P. and sacrificed 14 days later. The
number of CFU/lung was determined by quantitative
culture (Figure 1B). Once again the number of CFU/
lung was slightly lower in the unimmunized phox KO
mice compared to C57Bl/6 controls. More striking was
the observation that both types of mice were completely
protected by immunization.
Representative images of the histological evaluation of
the infected lungs in non-immune B6 and gp91
phox KO
mice are shown in Figure 2. The most striking differ-
ence is that the B6 mouse lungs contain more mature
spherules than the gp91
phox KO mouse lungs do, as
would be expected from the quantitative culture data. In
both mouse strains the predominant cellular response is
neutrophilic. The inflammatory foci are larger in the
gp91
phox mice than in the controls, despite the smaller
number of spherules found in these lesions.
We also measured the amount of mRNA coding for
selected cytokines in the lungs of B6 and gp91
phox KO
mice infected with Coccidioides (Figure 3). We found
that the infected gp91
phox KO mice expressed higher
mRNA levels for all the cytokines tested compared to
the B6 mice, except for IL-4 and TGF-b1. The most
striking differences between the levels of mRNA in the
gp91
phox KO and B6 mice were in TNF-a (p = 0.012),
interferon-g (p = 0.008), IL-17a (p = 0.002), IL-22 (p =
0.003) and IL-23 (p = 0.002).
We wanted to compare the gp91
phox KO and control
mice in the more physiologic intranasal model of infec-
tion. In this model mortality is used as the endpoint
rather than quantitative culture. C57Bl/6 and gp91
phox
KO mice were infected with 150 arthroconidia intrana-
sally and observed for 30 days. The mortality curves are
s h o w ni nF i g u r e4 A .B o t hc o n t r o la n dg p 9 1
phox mice
died at the same rate after intranasal infection. To
determine whether the gp91
phox KO mice could be suc-
cessfully immunized in this model of infection, we
immunized the two strains of mice as described in
Materials and Methods and challenged them intranasally
with 250 arthroconidia. The immune mice were com-
pared to non-immune controls, which had been given
adjuvant only. The survival curves are shown in Figure
4B. With the larger challenge all the non-immune mice
died by day 20 and the gp91
phox KO mice died slightly
more quickly than the B6 mice (p = 0.023). In contrast,
7o f8i m m u n eB 6a n dg p 9 1
phox KO mice survived for
31 days (p < 0.001 for both B6 and gp91
phox compared
to non-immune control). There was no difference in
survival between the immune B6 and gp91
phox KO mice
(p = 0.715).
We compared the lethal effect of H2O2 on Aspergillus
fumigatus spores and C. immitis arthroconidia and
spherules. The results are shown in Figure 5. Clearly,
the arthroconidia require at least five times higher con-
centrations of H2O2 to kill them compared to Aspergil-
lus fumigatus spores. Similar results were seen in three
independent experiments. There was no difference in
Figure 1 The number of CFU of Coccidioides found in the lungs
of gp91
phox KO and B6 controls 14 days after intraperitoneal
infection. Each symbol represents a mouse; the line represents the
median. Panel A: non-immune mice. Panel B: Immune and non-
immune mice of the two strains are compared.
Margolis et al. BMC Microbiology 2011, 11:71
http://www.biomedcentral.com/1471-2180/11/71
Page 3 of 7the susceptibility of spherules and arthroconidia to
H2O2 (Figure 5B). We did not test susceptibility to any
other reactive oxygen species.
Discussion
The objective of this study is to determine what effect the
deletion of gp91 phox had on the innate and acquired
immune response to Coccidioides.W ee x a m i n e dt h e
responses to two different routes of infection: intraperito-
neal, which is not physiologic but has quantitative culture
as an endpoint, and intranasal resulting in primary rather
than hematogenous pulmonary infections. In the latter
model mortality was the endpoint. Although intraperito-
neal infection is not the physiologic natural route of infec-
tion, the studies done so far in many laboratories have not
identified any major differences in the immunological pro-
tective mechanisms required for coping with intraperito-
neal versus intranasal infection. In both circumstances
T-cell mediated immunity is required and a Th-1 immune
response is important [18,21,22]. Furthermore, the genet-
ics of resistance to Coccidioides infection by these two
routes is very similar (unpublished observation) [10,23].
The only significant difference documented between the
two routes of infection so far is that some vaccines that
are protective in the intraperitoneal model are not protec-
tive in the intranasal model [24]. C57BL/6 mice are extre-
mely susceptible to intranasal infection with Coccidioides
so that very small difference in inoculum can have major
effects on mortality rate. We have found that the intraperi-
toneal route of infection is more reproducible and predict-
able, so we chose to do preliminary experiments using this
model. In both these infection models, the gp91 phox
mutation had no effect on acquired immunity to Ag2/
PRA. These data suggest that reactive oxygen intermedi-
ates may not be required for protective immunity.
The situation in non-immune mice is less clear. In the
intraperitoneal model of infection, the gp91
phox KO
Figure 2 Hematoxylin and eosin stained sections of lungs from gp91
phox KO mice (panels A and B) and B6 mice (panels C and D)
14 days after intraperitoneal infection. Panels A and C: 2X magnification: panels B and D: 40X magnification. The arrowheads in panel B and
D indicate spherules.
Figure 3 The amount of mRNA for the indicated cytokines
found in the lungs of gp91
phox KO and B6 control mice 14
days after intraperitoneal infection. The bars represent the mean
and the error bars the standard deviation. The amount of each of
the cytokines in the uninfected B6 mice was set at 1.
Margolis et al. BMC Microbiology 2011, 11:71
http://www.biomedcentral.com/1471-2180/11/71
Page 4 of 7mice had significantly fewer organisms in their lungs
compared to the controls. This may be due to the more
exuberant inflammatory response seen in the gp91
phox
KO mice compared to the B6, as measured by histology
and amount of Th1 and Th17 cytokine mRNA in the
infected lung. In the intranasal model of infection, no
difference between the gp91
phox KO and B6 was seen
when the mice were challenged with 150 arthroconidia,
but there was a small difference in survival between the
two mouse strains when they were challenged with a
larger number of organisms. The increased mortality
r a t em a ya l s ob ed u et oam o r ev i g o r o u si n f l a m m a t o r y
response in the gp91
phox KO mice.
We also found that C. immitis arthroconidia and
spherules were significantly more resistant to killing by
H2O2 than Aspergillus fumigatus spores. gp91
phox KO
mice are susceptible to pulmonary Aspergillus infection,
so this is a potential explanation for the difference in
susceptibility of the gp91
phox KO to these two fungi.
However, since it is not clear that ROI kill fungi directly
(see below) the significance of this observation is not
clear.
More studies in CGD mice have been done with the
gp47
phox KO rather than the gp91
phox KO. Mice with
both mutations have the CGD phenotype but there may
be differences between the two. The observation that
gp47
phox KO and gp91
phox K Om i c em a k eam o r e
robust inflammatory response than control mice with an
intact respiratory burst has been previously made in
mice experimentally infected with Aspergillus fumigatus
[25] or in mice given intra-tracheal zymosan [26,27].
The mechanism of this exaggerated inflammatory
response to Aspergillus fumigatus infection was thought
to be a defect in a superoxide dependent step in trypto-
phan metabolism [26]. The exaggerated response to
z y m o s a ni ng p 4 7
phox mice was thought to be due to a
failure to activate Nrf2, a redox-sensitive anti-inflamma-
tory regulator [26].
The mechanism by which phagocytes inhibit and
damage fungi is complex. NADPH oxidase is not required
for phagocyte killing of Aspergillus fumigatus conidia
[28,29]. This growth phase of Aspergillus fumigatus is
inhibited by lactoferrin-mediated iron depletion [28]. In
contrast, inhibition of the hyphal form of Aspergillus fumi-
gatus requires NADPH oxidase [28,30]. Aspergillus nidu-
lans lacking the catalase genes are capable of causing
Figure 4 Survival of groups of 8 gp91
phox KO and B6 mice
after intranasal infection with 150 (Panel A) or 250 (Panel B)
arthroconidia. In panel B immune and non-immune mice are
compared.
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Figure 5 The susceptibility of fungal spores to H2O2. A: Survival
of C. immitis arthroconidia and A. fumigatus spores after 45 minutes
exposure to the indicated concentrations of H2O2. B: Survival of
C. immitis arthroconidia and spherules to 45 minutes exposure to
the indicated concentrations of H2O2. In both cases the mean and
S.E.M. is plotted.
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phox KO mice, which suggested that reac-
tive oxygen intermediates might not be inhibiting the
organism directly [30]. It has been suggested that activa-
tion of intracellular proteases by reactive oxygen inter-
mediates is important for killing Candida and several
types of bacteria [31]. There is one report that administra-
tion of pentraxin 3 protected gp47
phox mice from experi-
mental Aspergillus fumigatus infection, suggesting that this
molecule in important for resistance to Aspergillus fumiga-
tus and may be lacking in CGD mice [32].
T h eo n l ye v i d e n c et h a tp r i m a r yp a t h o g e n i cf u n g ia r e
more virulent in CGD mice is a study with Sporothrix
schenckii [33]. These investigators found that gp91
phox
KO mice infected with Sporothrix schenckii intrader-
mally died within three months, whereas control mice
survived this infection. They also found that PMN from
gp91
phox KO mice were not able to control the growth
of Sporothrix schenckii as well as the controls. We have
not been able to find any published data on Blastomyces
dermatitidis, C. immitis or Histoplasma capsulatum
experimental infections in CGD mice.
People with chronic granulomatous disease have
increased susceptibility to Aspergillus infections and, to
a lesser extent, infections due to other opportunistic
fungi [34]. There have been no reports of increased sus-
ceptibility to the primary pathogenic fungi Coccidioides,
Histoplasma capsulatum, Blastomyces dermatitidis or
Sporothrix schenckii. One expert states that these infec-
tions are not a problem in chronic granulomatous
disease [34]. One CGD patient has been observed to
recover uneventfully from pulmonary coccidioidomyco-
sis without anti-fungal therapy (J. Galgiani, personal
communication).
The observation that NADPH oxidase is not required
for a protective immune response to experimental cocci-
dioidomycosis raises the question of what immune
mechanisms used to kill spherules and endospores
in vivo. One potential protective immune effector
mechanism is oxidative stress due to nitric oxide. We
have previously reported that IL-10 exacerbates the
course of experimental coccidioidomycois and inhibits
nitric oxide synthase [35]. On the other hand, a very
recent study suggests that Coccidioides is resistant to kill-
ing by NO and that mice with a deletion mutation in
i n d u c i b l en i t r i co x i d es y n t h a s ea r ea b l et ok i l lCocci-
dioides [36]. Coccidioides spherules can be very large
(more than 60 μM in diameter) and therefore difficult to
phagocytose. Perhaps inhibiting the growth of the endo-
spore controls the growth of the organism. Understand-
ing the mechanisms of protective immunity is important
for optimally preventing and treating infections with this
pathogenic fungus. These finding may also be relevant
for other primary pathogenic fungi, such as Histoplasma
capsulatum and Paracoccidioides brasiliensis.
Conclusions
Mice with the CGD phenotype are not more susceptible
to Coccidioides immitis infection and they are comple-
tely protected by effective immunization. This suggests
that some mechanism other than reactive oxygen inter-
mediates may be responsible for protective immunity.
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